Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.

Hemasphere

Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

Published: September 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365332	PMC
http://dx.doi.org/10.1097/HS9.0000000000000759	DOI Listing

Publication Analysis

genotype intensive

intensive pretreatment

pretreatment influence

influence outcome

outcome acute

acute myeloid

myeloid leukemia

leukemia patients

patients treated

treated venetoclax

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!